BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 19478123)

  • 1. Granulomatous bronchiolitis of Crohn's disease successfully treated with inhaled budesonide.
    Trow TK; Morris DG; Miller CR; Homer RJ
    Thorax; 2009 Jun; 64(6):546-7. PubMed ID: 19478123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Granulomatous bronchiolitis associated with Crohn's disease.
    Vandenplas O; Casel S; Delos M; Trigaux JP; Melange M; Marchand E
    Am J Respir Crit Care Med; 1998 Nov; 158(5 Pt 1):1676-9. PubMed ID: 9817724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bronchiolitis associated with ulcerative colitis].
    Serrano J; Plaza V; Franquet T; Giménez A; Rubio J
    Arch Bronconeumol; 1996 Mar; 32(3):151-4. PubMed ID: 8634796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case of steroid-resistant Crohn's-associated bronchiolitis in the setting of quiescent gastrointestinal disease treated with infliximab.
    Chuah CS; Noble C; Leitch A
    BMJ Case Rep; 2018 Nov; 11(1):. PubMed ID: 30567117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of controlled-release budesonide in preserving bone mineral density in patients with Crohn's disease.
    Abreu MT
    Nat Clin Pract Gastroenterol Hepatol; 2005 May; 2(5):210-1. PubMed ID: 16265201
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of active and postactive ileal and colonic Crohn's disease with oral pH-modified-release budesonide. German Budesonide Study Group.
    Caesar I; Gross V; Roth M; Andus T; Schmidt C; Raedsch R; Weber A; Gierend M; Ewe K; Schölmerich J
    Hepatogastroenterology; 1997; 44(14):445-51. PubMed ID: 9164517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Budesonide for Crohn's disease.
    Seow CH; Benchimol EI; Steinhart AH; Griffiths AM; Otley AR
    Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):971-9. PubMed ID: 19611401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of budesonide and mesalamine for active Crohn's disease. International Budesonide-Mesalamine Study Group.
    Thomsen OO; Cortot A; Jewell D; Wright JP; Winter T; Veloso FT; Vatn M; Persson T; Pettersson E
    N Engl J Med; 1998 Aug; 339(6):370-4. PubMed ID: 9691103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Budesonide modified-release capsules.
    Baker DE
    Rev Gastroenterol Disord; 2001; 1(3):147-55. PubMed ID: 12120182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Journal scan.
    Wardrope J; Russell R
    J Accid Emerg Med; 2000 Sep; 17(5):368-70. PubMed ID: 11005414
    [No Abstract]   [Full Text] [Related]  

  • 11. Ectopıc spleen presentıng as an abdomınal mass ın a patıent wıth Crohn's dısease.
    Koçak E; Ergül B; Köklü S; Akbal E
    J Crohns Colitis; 2012 Apr; 6(3):394-5. PubMed ID: 22405183
    [No Abstract]   [Full Text] [Related]  

  • 12. Budesonide substitution in Crohn's disease relieves CNS toxicity of systemic steroids.
    Thomas MC; Schlup MM
    Med J Aust; 1998 Nov; 169(10):560. PubMed ID: 9861918
    [No Abstract]   [Full Text] [Related]  

  • 13. Initial therapy for mild to moderate Crohn's disease: mesalamine or budesonide?
    Feagan BG; Sandborn WJ
    Rev Gastroenterol Disord; 2002; 2 Suppl 2():S9-15. PubMed ID: 12478239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-inflammatory therapy reduces wheezing after bronchiolitis.
    Hakim A
    Arch Pediatr Adolesc Med; 1997 Jan; 151(1):108-9. PubMed ID: 9006545
    [No Abstract]   [Full Text] [Related]  

  • 15. The use of oral topically acting glucocorticosteroids in the treatment of inflammatory bowel disease.
    Rutgeerts P
    Mediators Inflamm; 1998; 7(3):137-40. PubMed ID: 9705597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of budesonide with prednisolone for active Crohn's disease.
    Rutgeerts P; Löfberg R; Malchow H; Lamers C; Olaison G; Jewell D; Danielsson A; Goebell H; Thomsen OO; Lorenz-Meyer H
    N Engl J Med; 1994 Sep; 331(13):842-5. PubMed ID: 8078530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe pulmonary disease in association with Crohn's disease in a 13-year-old girl.
    Bentur L; Lachter J; Koren I; Ben-Izhak O; Lavy A; Bentur Y; Rosenthal E
    Pediatr Pulmonol; 2000 Feb; 29(2):151-4. PubMed ID: 10639206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Observation of the effect of poly-IC combined with budesonade inhalation on treating infants with bronchiolitis].
    Luo CS; He LY; Mai ZG
    Zhonghua Er Ke Za Zhi; 2005 Sep; 43(9):700-1. PubMed ID: 16191311
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of Crohn's disease at the turn of the century.
    Bickston SJ; Cominelli F
    N Engl J Med; 1998 Aug; 339(6):401-2. PubMed ID: 9691110
    [No Abstract]   [Full Text] [Related]  

  • 20. Budesonide: its role in Crohn's disease therapy.
    Coleman CI; Reddy P; White CM
    Conn Med; 2002 Sep; 66(9):523-6. PubMed ID: 12369546
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.